The global colorectal cancer molecular diagnostics market is poised for significant growth, with projections indicating a remarkable surge to USD 5.07 billion by 2032, according to recent market ...

The recent approvals and robust pipeline activity are expected to fuel the market of molecular glues in the 7MM during the forecast period 2025-2034 due to factors like improved diagnosis, treatment ...

DelveInsight's Molecular Glues Market Insights report includes a comprehensive understanding of current treatment practices, ...

A new precision oncology paper was published in Oncotarget, Volume 16, on March 12, 2025, titled “Worldwide Innovative ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Molecular Partners (MOLN – Research Report), ...

Rua Dr. Diogo de Faria, 1087 – 9º andar – Vila Clementino 04037-003 São Paulo/SP - Brasil E-mail: [email protected] ...

Swiss pharmaceutical company Roche announced Friday it will open an innovation center in the Harvard University Enterprise Research Campus in Allston that could employ hundreds. The Roche ...

Half of the patients who received an experimental vaccine for pancreas cancer being developed by Roche and BioNTech following surgery in a small, early trial were still alive, most without disease ...

Kokoris came up with the idea of solving some of the noise issue of nanopore sequencing by converting DNA into larger surrogate polymers, and he cofounded sequencing company Stratos Genomics back in ...

It exists in two main isoforms: ChREBPα and ChREBPβ. This is the first study to identify and develop small molecules—termed "molecular glues"—that enhance the interaction between ChREBPα ...

Stage 2 of the NIH-sponsored phase 3 OUtMATCH trial—the first head-to-head study of Xolair versus OIT—met its primary endpoint, Roche's Genentech said in a Sunday press release.